PathogenDx Plans Microarray-Based UTI Test as Focus Remains on Clinical Market

Thu, May 4

After having cut its teeth on the cannabis, food, and COVID-19 testing markets, MATTIO client @PathogenDX is now poised to launch a microarray-based test for urinary tract infections. Via @360DxNews: https://t.co/HXHCsX63Oh

153

After having cut its teeth on the cannabis, food, and COVID-19 testing markets, PathogenDx is now poised to launch a microarray-based test for urinary tract infections.

Discover